Back

Predictors for hemodynamic changes in parallel lesions following revascularization in multivessel coronary artery disease

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1) - Interventional cardiology (1) Intracoronary Flow and Pressure Measurements EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Mr Johannes Michael Altstidl

Friedrich Alexander University Erlangen Nuernberg, Erlangen (Germany)

6 More presentations in this session

Presentation thumbnail
Prevalence of atrial fibrillation and its association with INOCA endotypes: insights from the INOCA-IT registry.
Doctor D. Galante (Rome, IT)
Abstract
Presentation thumbnail
Comparative outcomes of fractional flow reserve and intravascular ultrasound guidance for percutaneous coronary intervention: a systematic review and meta-analysis
Doctor E. Jamileh (Blackburn, GB)
Abstract Slides
Presentation thumbnail
Safety and outcomes of iFR vs. FFR in coronary revascularization: a real-world cohort study
Mr D. Ferreira (Lisbon, PT)
Abstract
Presentation thumbnail
QFR vs. FFR: 5-year outcomes of patients treated for intermediate coronary artery stenoses in chronic coronary artery disease
Miss G. Ziubryte (Kaunas, LT)
Abstract Slides
Presentation thumbnail
Through the mesh - coronary access after TAVI
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1) - Interventional cardiology (1)

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026
You may be interested in
thumbnail
Congress Presentation
Nuclear cardiology is best for risk assessment
thumbnail
Congress Presentation
Intracoronary imaging: from research tool to class IA in the Guidelines
thumbnail
Congress Presentation
Beyond the stenosis: physiological assessment in modern coronary artery disease management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources